Navigation Links
De nouvelles directives recommandent la fidaxomicine pour tous les patients pouvant suivre un traitement antibiotique par voie orale pour une infection à Clostridium difficile
Date:10/29/2013

Engl J Med. 2008;359(18):1932−1940.

11. Cornely OA et al. Fidaxomicin versus vancomycin for infection with Clostridium difficile in Europe, Canada, and the USA: a double-blind, non-inferiority, randomised controlled trial. Lancet Infect Dis. 2012;12:281-289.

12. Cornely OA et al. Resolution of Clostridium difficile-Associated Diarrhea in Patients With Cancer Treated With Fidaxomicin or Vancomycin. J Clin Onc. 2013;31(19):2493-2499.

13. Mullane KM et al. Efficacy of Fidaxomicin Versus Vancomycin as Therapy for Clostridium difficile Infection in Individuals Taking Concomitant Antibiotics for Other Concurrent Infections. Clin Infect Dis. 2011;53(5):440-447.

14. Mullane KM et al. Renal impairment and clinical outcomes of Clostridium difficile infection in two randomized trials. Am J Nephrol. 2013;38(1):1-11.

15. Loo VG et al. A predominantly clonal multiinstitutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med. 2005;353 (23):2442-2449.

16. Campbell R et al. Length of stay and hospital costs among high-risk patients with hospital-origin Clostridium difficile-associated diarrhea. J. Med Econ. 2013;16(3):440-448.

17. Kim JH et al. Clostridium difficile infection in a long-term care facility: hospital-associated illness compared with long-term care-associated illness. Infect Control Hosp Epidemiol. 2011;32(7):656-660.

18. Zilberberg MD et al. Clostridium difficile-associated disease and mortality among the elderly critically ill. Crit Care Med. 2009;37(9):2583-2589.

19. Bauer MP et al. European Society of Clinical Microbiology and Infectious Diseases (ESCMID): treatmen
'/>"/>

SOURCE Astellas Pharma Europe Ltd
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Medicare Procurement Program Creates Extreme Hardships For North Carolina Patients, Says AAHomecare
2. Strong Efficacy Data Prompt Charleston Laboratories to Halt Phase 3 Study of CL-108 in Patients with Moderate to Severe Acute Pain
3. Lumena Pharmaceuticals Initiates the CLARITY Phase II Study of LUM001 in Patients with Primary Biliary Cirrhosis
4. 3SBio to Develop DJ5 for Progressive Renal Failure in ADPKD Patients
5. Juventas Therapeutics completes enrollment of Phase II STOP-HF study of JVS-100 in patients with symptomatic heart failure
6. Medicare Procurement Program Creates Extreme Hardships for Patients without Options, Says AAHomecare
7. Media Sourcerys Secure Mobile Workflow App Deployed by CCS Medical to Expedite Product Delivery to Patients
8. Lamotrigine is One of the Most Commonly Prescribed Drugs Among Newly Diagnosed Bipolar Disorder Patients in the United States
9. Among Newly Diagnosed Type 2 Diabetes Patients, DPP-IV Inhibitors are the Leading Oral Therapies After Standard Metformin and Sulfonylurea
10. Should Mircera Reach the U.S. Market, Surveyed Nephrologists State that at Least 40 Percent of CKD-ND and Dialysis Patients are Likely Candidates
11. Ampio Pharmaceuticals subsidiary Luoxis Diagnostics announces positive summary data from study of traumatic brain injury patients and issuance of companys third US patent for its oxidation-reduction potential diagnostic platform
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... FORT LAUDERDALE, Fla. , July 2, 2015 ... & Co., is pleased to announce that its ... Inc. ("Insight Beverages") to Kerry Group plc (ISE: ... focused on taste and nutrition systems, as well ... food, beverage and pharmaceutical markets. Farlie Turner served ...
(Date:7/2/2015)... 2, 2015  Before you head outdoors with your family ... stay safe and healthy. Take steps to protect yourself from ... Protect Your Skin From the Sun ... increase your risk of skin cancer. To protect your skin ... possible, especially during midday hours. Wear a hat with a ...
(Date:7/2/2015)... 2015 Releases of the genetically ... aegypti , , reduced the dengue mosquito population ... by 95%, well below the modelled threshold for ... The journal PLOS Neglected Tropical Diseases published ... engineered mosquitoes. The results showed that in Juazeiro city, ...
Breaking Medicine Technology:Farlie Turner's Consumer Group Completes Sale of Insight Beverages to Kerry 2First Aid Summer Survival Tips from Nyack Hospital 2First Aid Summer Survival Tips from Nyack Hospital 3Oxitec Mosquito Works to Control Aedes aegypti in Dengue Hotspot 2Oxitec Mosquito Works to Control Aedes aegypti in Dengue Hotspot 3
... Study Shows GlucAffect Reduces Blood ... , CHESTERFIELD, Mo., July 16 A clinical ... a nutritional supplement developed by Reliv International, Inc. (Nasdaq: RELV ... participants. , , The study included 50 ...
... LEXINGTON, Massachusetts, July 16 Shire plc,(LSE: SHP, ... it has received Fast Track designation from the U.S. Food ... development for the treatment of Type I Gaucher disease. Shire ... for the filing of its,NDA. , ...
Cached Medicine Technology:Reliv International's GlucAffect(TM) Proven Effective in Clinical Study 2Shire Receives Fast Track Designation for velaglucerase alfa for Gaucher Disease 2Shire Receives Fast Track Designation for velaglucerase alfa for Gaucher Disease 3Shire Receives Fast Track Designation for velaglucerase alfa for Gaucher Disease 4
(Date:7/2/2015)... ... July 02, 2015 , ... CleanItSupply.com, ... it has reached an agreement to acquire eRubbermaid.com, an Internet retailer of ... Rubbermaid Commercial Products on the web today. , “eRubbermaid.com’s search ...
(Date:7/2/2015)... ... July 02, 2015 , ... Scientists at the ... $4 million through five federal grants to study a group of related mosquito-borne ... diseases. , The research will be conducted in the Regional Biocontainment Laboratory ...
(Date:7/2/2015)... Kan. (PRWEB) , ... July 02, 2015 , ... ... dedicated exclusively to healthcare providers, has been retained to lead a national ... of the top executive search firms in the healthcare industry, B. E. Smith ...
(Date:7/2/2015)... ... July 02, 2015 , ... ... company, is announcing with their launch an intention to partner with companies that ... solutions on the planet. Their innovative water soluble, Cannabidiol (CBD) formulations, combined with ...
(Date:7/2/2015)... ... , ... A team of quality control (QC) experts at GE Healthcare, led ... for enhanced workflow. Now, Dr. Dunne’s lab has set a lofty goal: to become ... Imaging network. , Join the team members for a new, free educational ...
Breaking Medicine News(10 mins):Health News:CleanItSupply.com Acquires eRubbermaid.com 2Health News:Mosquito-Borne Viruses Subject of $4M in Federal Grants to Scientists in Pitt’s Center for Vaccine Research 2Health News:Mosquito-Borne Viruses Subject of $4M in Federal Grants to Scientists in Pitt’s Center for Vaccine Research 3Health News:Mosquito-Borne Viruses Subject of $4M in Federal Grants to Scientists in Pitt’s Center for Vaccine Research 4Health News:Nicklaus Children’s Hospital Retains B. E. Smith to Recruit New Chief Operating Officer 2Health News:Nicklaus Children’s Hospital Retains B. E. Smith to Recruit New Chief Operating Officer 3Health News:New Water Soluble CBD Provides Manufacturers & Distributors a More Effective, Safe, & Cost Efficient Alternative to Traditional CBD Oil 2Health News:New Water Soluble CBD Provides Manufacturers & Distributors a More Effective, Safe, & Cost Efficient Alternative to Traditional CBD Oil 3Health News:GE Healthcare Webinar Spotlights GE’s Own, Internal QC Lab Enhancements with Six Sigma 2Health News:GE Healthcare Webinar Spotlights GE’s Own, Internal QC Lab Enhancements with Six Sigma 3
... and its,affiliates (IBC) and Abington Memorial Hospital announced ... their long-standing,relationship. "We are pleased to continue ... Jones, Jr., president and chief executive officer,of Abington ... and patient,safety, as demonstrated by its history of ...
... Spanish . , ANN ARBOR, Mich. Is a fear ... one in five American women still smokes, and many dont try ... stubborn persistence of smoking, fear of weight gain is high on ... System researcher who has devoted much of her career to studying ...
... food -- sleep often suffers, study says , TUESDAY, Nov. ... high-fat diet -- it disrupts the body,s 24-hour internal (circadian) ... daily rhythms of many metabolic functions, U.S. researchers say. , ... found that mice fed a high-fat diet gained weight and ...
... Microflex(R) Corporation, a leader,in the development and ... BarrierSafe Solutions International, announced today that,BSSI has been ... In addition to Microflex(R), BSSI also owns ... NV, is a leading supplier,of health and safety ...
... Eighty-nine percent,of Bates College students who worked with ... care-related graduate programs for fall,2007 matriculation were accepted., ... by the committee, 32 of 36 Bates,applicants to ... accepted. Nationally, about 45 percent of applicants to ...
... successfully Design-her,Gals website, http://www.designhergals.com will continue ... for wishes" campaign to grant dreams,this holiday season ... families,through the Gal to Gal Foundation, the non-profit ... Stage 4 breast cancer patients. During October,s ...
Cached Medicine News:Health News:Independence Blue Cross and Abington Memorial Hospital Reach Multi-Year Agreement 2Health News:Is fear of gaining weight keeping many women from trying to quit smoking? 2Health News:Is fear of gaining weight keeping many women from trying to quit smoking? 3Health News:Is fear of gaining weight keeping many women from trying to quit smoking? 4Health News:High-Fat Diet Can Disrupt Body's Clock 2Health News:Microflex(R) Corporation Acquired by Linden and Edgewater 2Health News:Graduate Programs in Health Care Accept 89 Percent of Bates College Applicants 2Health News:Design-her Gals(TM) Announces the Ground-Breaking Virtual On-Line Walk for Wishes to Grant Dreams for Stage IV Breast Cancer Patients this Holiday Season Through Gal to Gal Foundation 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: